Tiletamine

From Self-sufficiency
Revision as of 18:42, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Tiletamine
File:Tiletamine.svg
Systematic (IUPAC) name
2-ethylamino-2-(2-thienyl) cyclohexanone
Clinical data
Routes of
administration
IV, IM, SC, Other
Legal status
Legal status
Pharmacokinetic data
Metabolism Liver
Excretion Kidneys
Identifiers
ATC code none
PubChem CID 26533
Chemical data
Formula C12H17NOS
Molar mass 223.34 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tiletamine is a dissociative anesthetic and pharmacologically classified as an NMDA receptor antagonist. It is related chemically and pharmacologically to other anesthetics in this family such as ketamine and phencyclidine. Tiletamine hydrochloride exists as odourless white crystals.

It is used in veterinary medicine in the compound product Telazol (tiletamine/zolazepam, 50 mg/ml of each in 5 ml vial) as an injectable anesthetic. It is sometimes used in combination with xylazine (Rompun) to tranquilize large mammals such as bears and horses. Telazol is the only commercially available tiletamine product in the United States.

It is contraindicated in patients of an ASA score of III or greater and in animals with CNS signs, hyperthyroidism, cardiac disease, pancreatic or renal disease, pregnancy, glaucoma, or penetrating eye injuries.

Tiletamine products are classified as Schedule III controlled substances in the United States.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


ja:チレタミン